cilastatin
Facts
11 properties- Instance of
- type of chemical entity
- Subclass of
- 7-[(2-amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)-oxomethyl]amino]-2-heptenoic acid
- Has use
- medication
- Canonical SMILES
- CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C
- Chemical formula
- C₁₆H₂₆N₂O₅S
- Isomeric SMILES
- CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C
- Mass
- 358.156243 Da
- Medical condition treated
- bacterial infectious disease
- Stereoisomer of
- 7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]-oxomethyl]amino]-2-heptenoic acid
- Subject has role
- protease inhibitor
- World Health Organisation international non-proprietary name
- cilastatin
- OpenAlex ID
- C2777437143, C2781255259
- CAS Registry Number
- 82009-34-5
- ChEBI ID
- 3697
- ChEMBL ID
- CHEMBL766
- ChemSpider ID
- 4940183
- DSSTOX compound identifier
- DTXCID3028213
- DSSTox substance ID
- DTXSID8048238
- DrugBank ID
- DB01597
- DrugCentral ID
- 640
- EC number
- 279-875-8
- ECHA Substance Infocard ID
- 100.072.592
- Freebase ID
- /m/08dz0k
Show all 33 identifiers +21
- Guide to Pharmacology Ligand ID
- 5166
- Human Metabolome Database ID
- HMDB0015535
- InChIKey
- DHSUYTOATWAVLW-WFVMDLQDSA-N
- MassBank accession ID
- MSBNK-Athens_Univ-AU212901, MSBNK-Athens_Univ-AU212902, MSBNK-Athens_Univ-AU212903, MSBNK-Athens_Univ-AU212904, MSBNK-Athens_Univ-AU212907, MSBNK-Athens_Univ-AU212908, MSBNK-Athens_Univ-AU212909, MSBNK-Athens_Univ-AU212930, MSBNK-Athens_Univ-AU212932, MSBNK-Athens_Univ-AU212933, MSBNK-Athens_Univ-AU212934, MSBNK-Athens_Univ-AU212951
+26 more
MSBNK-Athens_Univ-AU212952, MSBNK-Eawag-EA255501, MSBNK-Eawag-EA255502, MSBNK-Eawag-EA255503, MSBNK-Eawag-EA255504, MSBNK-Eawag-EA255505, MSBNK-Eawag-EA255506, MSBNK-Eawag-EA255507, MSBNK-Eawag-EA255508, MSBNK-Eawag-EA255509, MSBNK-Eawag-EA255510, MSBNK-Eawag-EA255511, MSBNK-Eawag-EA255512, MSBNK-Eawag-EA255513, MSBNK-Eawag-EA255514, MSBNK-Eawag-EA255551, MSBNK-Eawag-EA255552, MSBNK-Eawag-EA255553, MSBNK-Eawag-EA255554, MSBNK-Eawag-EA255555, MSBNK-Eawag-EA255556, MSBNK-Eawag-EA255558, MSBNK-Eawag-EA255559, MSBNK-Eawag-EA255560, MSBNK-Eawag-EA255561, MSBNK-Eawag-EA255564 - MeSH concept ID
- M0023687
- MeSH descriptor ID
- D015377
- MeSH tree code
- D02.455.426.392.368.533.200, D10.251.355.325.200
- Microsoft Academic ID (discontinued)
- 2777437143
- NDF-RT ID
- N0000147771
- Probes And Drugs ID
- PD009460
- PubChem CID
- 6435415
- Reaxys registry number
- 6895069
- RxNorm CUI
- 2540
- Römpp online ID
- RD-03-01846
- SPLASH
- splash10-0uxr-0292000000-fc9fdc71c26de516aa47, splash10-0f89-0980000000-c7e9f3733dc9d5876f69, splash10-0f89-0940000000-5e461031ed3e8be30dce, splash10-0a4i-0009000000-ef2198c6225f95e6b765, splash10-004i-0092000000-f0483d6314128c99a866, splash10-0udl-0197000000-ed9524572e0f6a20cf73, splash10-0a4i-0009000000-92adcd25c03169bce114, splash10-0002-9350000000-49e92e77b9da299b75c9, splash10-0002-9100000000-93ce7c9a2d2ddb232af8, splash10-0002-9100000000-a5fb73965dbd68cad5ca, splash10-0002-9000000000-314ddc83e7521820bbfc, splash10-0002-9000000000-f4a4b127adc8552d8fff
+17 more
splash10-0a4i-0009000000-ee64e7f7019c68d1b37c, splash10-0002-9340000000-52a3fa17dbbe9e3a1655, splash10-0002-9100000000-455b80c43f8c12b3f0fc, splash10-0002-9000000000-07045a080f03625d01af, splash10-0002-9000000000-8832abb1f60cae723d4a, splash10-00kb-9000000000-92b4d4d580bdc8669cd2, splash10-0udl-0197000000-a5c912d56f6b1064113a, splash10-03fr-0089000000-e23865517b151264287c, splash10-0a4i-0009000000-f94440db25517ee87789, splash10-004i-0193000000-9c52bb64f789ddf44d03, splash10-01t9-0890000000-a16bc40171fdaad5d00f, splash10-01q9-0900000000-7f6fb4bc2c8d8b74669a, splash10-001i-0900000000-f7395a558e6db43df825, splash10-0a4i-0009000000-65b5dae5f837cb16f232, splash10-004i-0093000000-f41454497f85c6c231e3, splash10-004i-0890000000-2d4e1ce343461b9c33ff, splash10-03fr-0079000000-f5a7ea868a31218529fb - SureChEMBL ID
- 37051
- UMLS CUI
- C0008777
- UNII
- 141A6AMN38
- UniChem compound ID
- 631807
Belongs to 2
Has use 1
Medical condition treated 1
Subject has role 1
← Drug or therapy used for treatment 1
0 sources
Summary
cilastatin is a type of chemical entity[1]. cilastatin is a type of 7-[(2-amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)-oxomethyl]amino]-2-heptenoic acid[2].
Key Facts
- Canonical SMILES: CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C[3]
- Chemical formula: C₁₆H₂₆N₂O₅S[4]
- Has use: medication[5]
- Isomeric SMILES: CC1(C[C@@H]1C(=O)N/C(=C\CCCCSCC@@HN)/C(=O)O)CC@@HN)/C(=O)O)C">[6]
- Mass: 358.156243 dalton[7]
- Medical condition treated: bacterial infectious disease[8]
- World Health Organisation international non-proprietary name: cilastatin[9]
- Subject has role: protease inhibitor[10]
- Stereoisomer of: 7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]-oxomethyl]amino]-2-heptenoic acid[11]